Table 1.
Whole Population |
No AF (AF−) |
AF+ | SAF | |||||||
---|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % |
p (AF− vs. AF) |
N | % |
p (AF− vs. SAF) |
|
Age (years, mean ± SD) | 77.5 | 7.9 | 76.8 | 7.9 | 80.0 | 7.4 | <0.001 | 80.9 | 7.4 | <0.001 |
Male gender | 1535 | 50.9% | 1122 | 48.1% | 413 | 60.7% | <0.001 | 191 | 68.5% | <0.001 |
MI | 446 | 14.8% | 321 | 13.8% | 125 | 18.4% | 0.003 | 45 | 16.1% | 0.294 |
CHD | 666 | 22.1% | 444 | 19.0% | 222 | 32.6% | <0.001 | 84 | 30.1% | <0.001 |
Thyroid diseases | 418 | 13.9% | 301 | 12.9% | 117 | 17.2% | 0.005 | 42 | 15.1% | 0.337 |
Pulmonary diseases | 361 | 12.0% | 264 | 11.3% | 97 | 14.3% | 0.040 | 32 | 11.5% | 0.974 |
Thromboembolism | 241 | 8.0% | 166 | 7.1% | 75 | 11.0% | 0.001 | 23 | 8.2% | 0.513 |
LEAD | 415 | 13.8% | 286 | 12.3% | 129 | 19.0% | <0.001 | 51 | 18.3% | 0.005 |
ICS/TIA | 366 | 12.1% | 246 | 10.5% | 120 | 17.6% | <0.001 | 53 | 19.0% | <0.001 |
PCI/CABG | 368 | 12.2% | 270 | 11.6% | 98 | 14.4% | 0.043 | 44 | 15.8% | 0.040 |
DM | 881 | 29.2% | 628 | 26.9% | 253 | 37.2% | <0.001 | 98 | 35.1% | 0.004 |
Heart failure | 673 | 22.3% | 396 | 17.0% | 277 | 40.7% | <0.001 | 96 | 34.4% | <0.001 |
HA | 2433 | 80.7% | 1856 | 79.5% | 577 | 84.9% | 0.001 | 223 | 79.9% | 0.821 |
CKD | 1005 | 33.3% | 695 | 29.8% | 310 | 45.6% | <0.001 | 144 | 51.6% | <0.001 |
Physical activity | 1294 | 42.9% | 1039 | 44.5% | 255 | 37.5% | 0.001 | 103 | 36.9% | 0.017 |
BMI ≥ 30 | 923 | 30.6% | 686 | 29.4% | 237 | 34.9% | 0.005 | 88 | 31.5% | 0.419 |
hs CRP > 5 mg/L | 565 | 18.7% | 434 | 18.6% | 131 | 19.3% | 0.659 | 56 | 20.1% | 0.603 |
NT pro-BNP > 125 pg/mL | 2288 | 75.9% | 1690 | 72.4% | 598 | 87.9% | <0.001 | 247 | 88.5% | <0.001 |
AF—atrial fibrillation. SAF—silent atrial fibrillation. MI—myocardial infarction CHD—coronary heart disease; LEAD—lower extremity artery disease. ICS—ischemic cerebral stroke; TIA—transient ischemic attack; DM—diabetes mellitus; HA—arterial hypertension; CKD—chronic kidney disease; BMI—body mass index.